AntibioticMech

triclosan

CHEBI:164200 ·resolve ·ANTIBACTERIAL ·EXACT SEEDED

An aromatic ether that is phenol which is substituted at C-5 by a chloro group and at C-2 by a 2,4-dichlorophenoxy group. It is widely used as a preservative and antimicrobial agent in personal care products such as soaps, skin creams, toothpaste and deodorants as well as in household items such as plastic chopping boards, sports equipment and shoes. — ChEBI

Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.

Classification

disinfecting agents and antisepticsARO:3005386

Strictly broader compounds or drug classes this molecule belongs to.

Chemical structure

Computed structure properties
Molecular formulaC12H7Cl3O2
Charge0
Average mass289.545 Da
Monoisotopic mass287.95116 Da
SourceChEBI
InChIKeyXEFQLINVKFYRCS-UHFFFAOYSA-N

SMILES

Oc1cc(Cl)ccc1Oc1ccc(Cl)cc1Cl

InChI

InChI=1S/C12H7Cl3O2/c13-7-1-3-11(9(15)5-7)17-12-4-2-8(14)6-10(12)16/h1-6,16H

Also called

Cross-references

Equivalent identifiers for this same structure in other resources.

Activity roles

Every antimicrobial role a source asserts for this compound — the unreduced evidence behind its antimicrobial_class.

Source concepts

Every upstream concept that resolved to this record. The merge is the product: this is what shows ChEBI and CARD are describing the same structure.

Upstream concepts merged into this record
SourceNative IDLabelMinted CURIEVersion
ARO ARO:3000870 triclosan antibioticmech:aro-f5e0894a20 2026-08-30
CHEBI CHEBI:164200 triclosan antibioticmech:chebi-4fb85f3941 2026-08-30

Molecular targets

The molecular entity or process this compound acts on. Each target carries evidence — this is a mechanistic claim, not a classification.

antibiotic sensitive enoyl-acyl carrier reductase PROTEIN DIRECT_BINDING_TARGET

ARO:3000872

CARD/ARO database assertion; target organism, strain, and assay are not specified. Enoyl-ACP reductase is asserted as the blocked enzyme. Evidence status: PRIMARY_EVIDENCE_NEEDED. Source: CARD_ARO 2026-08-30 (retrieved 2026-08-30).

Replicase polyprotein 1ab VIRAL_PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Severe acute respiratory syndrome coronavirus NCBITaxon:2901879

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 75000 nM Various Assay
This is a review article. Please point to the original journal.
RSID 1074309
assay 10079_1
monomer 8726
PMID:34798775
Organism-specific examples
ProteinGeneOrganismEntry
Replicase polyprotein 1ab UniProtKB:P0C6X7 Severe acute respiratory syndrome coronavirus REVIEWED

Trans-2-enoyl-ACP reductase II PROTEIN MEASURED_TARGET_ASSOCIATION

BindingDB quantitative measurement in the named target organism; source assay descriptions and identifiers are retained per measurement. Evidence status: PRIMARY_EVIDENCE. Source: BINDINGDB 2026-09 (retrieved 2026-08-31).

Streptococcus pneumoniae NCBITaxon:1313

Quantitative measurements
TypeReported valueAssayBindingDB IDsReference
IC50 >30000 nM Enzyme Inhibition Assay
Assays were carried out in half-area, 96-well microtiter plates. Compounds were evaluated in assay mixtures containing components specific for each enzyme. Inhibitors were varied over the range 0.01-10 uM. The consumption of NAD(P)H was monitored for 20 min at 30 °C by following the change in absorbance at 340 nm. IC50 values were estimated from a fit of the initial velocities to a standard equation. Triclosan was included in all assays as a positive control.
RSID 14752
assay 1080_1
monomer 8726
PMID:12699381
Organism-specific examples
ProteinGeneOrganismEntry
Probable nitronate monooxygenase UniProtKB:Q9FBC5 Streptococcus pneumoniae UNREVIEWED

Mechanism summary

Mode of action
CELL_MEMBRANE_SYNTHESIS_INHIBITION microbial target — CURATOR: Reassigned after review of FabI/enoyl-ACP reductase inhibition in bacterial fatty-acid synthesis; primary reports identify FabI rather than dihydrofolate reductase as the antibacterial target for triclosan. PMID:10196195; PMID:10201369; PMID:9707111.

Resistance mechanisms

10 known routes by which microbes resist this compound, grounded in ARO where CARD models them. Grouped by mechanism type — expand a group to see its determinants.

ANTIBIOTIC_EFFLUX 6
ANTIBIOTIC_EFFLUX
DeterminantARO IDOrganismGene familiesEvidence
AcrAB-TolC ARO:3000384 not organism-specific
  • ARO:3000384 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000870 (triclosan); database assertion, not a primary citation.)
Klebsiella pneumoniae KpnEF ARO:3004585 not organism-specific
  • ARO:3004585 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000870 (triclosan); database assertion, not a primary citation.)
MexJK ARO:3009148 not organism-specific
  • ARO:3009148 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000870 (triclosan); database assertion, not a primary citation.)
MexJK-OpmH ARO:3003691 not organism-specific
  • ARO:3003691 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000870 (triclosan); database assertion, not a primary citation.)
TriABC-OpmH ARO:3003678 not organism-specific
  • ARO:3003678 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000870 (triclosan); database assertion, not a primary citation.)
abeM ARO:3000753 not organism-specific
  • ARO:3000753 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000870 (triclosan); database assertion, not a primary citation.)
ANTIBIOTIC_TARGET_ALTERATION 4
ANTIBIOTIC_TARGET_ALTERATION
DeterminantARO IDOrganismGene familiesEvidence
Escherichia coli fabG mutations conferring resistance to triclosan ARO:3004049 not organism-specific
  • ARO:3004049 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000870 (triclosan); database assertion, not a primary citation.)
Escherichia coli fabI mutations conferring resistance to isoniazid and triclosan ARO:3004045 not organism-specific
  • ARO:3004045 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000870 (triclosan); database assertion, not a primary citation.)
Escherichia coli gyrA with mutation conferring resistance to triclosan ARO:3004335 not organism-specific
  • ARO:3004335 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000870 (triclosan); database assertion, not a primary citation.)
Salmonella enterica gyrA with mutation conferring resistance to triclosan ARO:3004334 not organism-specific
  • ARO:3004334 (CARD/ARO asserts confers_resistance_to_antibiotic ARO:3000870 (triclosan); database assertion, not a primary citation.)

Causal graphs

Evidence-backed mechanism graphs: how the compound reaches its target, what the target does, and how the effect propagates to growth inhibition or death.

Triclosan inhibits bacterial FabI fatty-acid synthesis MECHANISTIC

Triclosan forms a tight inhibited FabI-NAD-triclosan state, blocking bacterial enoyl-acyl carrier protein reductase activity in type II fatty-acid synthesis and limiting membrane lipid biosynthesis.

Nodes — triclosan_fabi_fatty_acid_synthesis_inhibition
NodeLabelTypeGrounding
triclosan triclosan COMPOUND CHEBI:164200
fabi bacterial FabI enoyl-ACP reductase GENE_OR_PROTEIN ARO:3000872
fabi_nad_triclosan_state inhibited FabI-NAD-triclosan state STATE REVIEWED_LABEL_ONLY
enoyl_acp_reductase_activity enoyl-acyl carrier protein reductase activity MOLECULAR_FUNCTION REVIEWED_LABEL_ONLY
type_ii_fatty_acid_biosynthesis type II fatty-acid biosynthesis PATHWAY REVIEWED_LABEL_ONLY
membrane_lipid_biosynthesis membrane lipid biosynthesis BIOLOGICAL_PROCESS REVIEWED_LABEL_ONLY
Edges — triclosan_fabi_fatty_acid_synthesis_inhibition
SubjectPredicateObjectEvidence
triclosan stabilizes fabi_nad_triclosan_state
  • PMID:10196195 (Heath and colleagues found that triclosan inhibits bacterial fatty-acid synthesis at FabI and increases FabI affinity for NAD+.)
fabi participates in fabi_nad_triclosan_state
  • PMID:10201369 (Levy and colleagues connected triclosan activity to FabI in bacterial cells.)
fabi_nad_triclosan_state inhibits enoyl_acp_reductase_activity
  • PMID:10196195 (Mechanistic FabI assays linked triclosan binding to inhibition of the enoyl-ACP reductase step.)
fabi enables enoyl_acp_reductase_activity
  • PMID:9707111 (McMurry and colleagues identified lipid synthesis as the triclosan target pathway and FabI as the sensitive enzyme.)
enoyl_acp_reductase_activity supports type_ii_fatty_acid_biosynthesis
  • PMID:10196195 (The FabI inhibition study placed the triclosan-sensitive step in the bacterial fatty-acid synthesis cycle.)
type_ii_fatty_acid_biosynthesis supports membrane_lipid_biosynthesis
  • PMID:9707111 (Lipid synthesis experiments connected triclosan-sensitive FabI activity to the broader lipid biosynthesis pathway.)

Curation history

  1. SEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Seeded from data/raw/ inventories (ARO, CHEBI)

  2. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  3. RESEEDED_FROM_SOURCES 2026-08-30 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  4. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  5. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  6. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  7. RESEEDED_FROM_SOURCES 2026-08-31 · seed_from_sources

    Re-seeded from updated data/raw/ inventories

  8. CURATED_CAUSAL_GRAPH 2026-09-04 · codex · LLM-assisted

    Added a PMID-supported causal graph for triclosan inhibition of bacterial FabI fatty-acid synthesis and marked the coarse mode of action as curator-reviewed.

Provenance

Seeded by scripts/seed_from_sources.py from the committed inventories in data/raw/. View the record.